Biogenix Molecular, LLC

Miami, Florida 33165

5 studies enrolling now · 16 studies all time

What they study most

B7H3, Biochemical Recurrence of Malignant Neoplasm of Prostate, Bladder Cancer, Bladder Urothelial Carcinoma, Breast Neoplasms, Castration Resistant Metastatic Prostate Cancer, Castration-Resistant Prostatic Cancer, Central Nervous System Pathology, Cervical Adenocarcinoma, Cervical Cancer, Cholangiocarcinoma, Colorectal Adenocarcinoma

Studies at this site

• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — Recruiting now
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — Recruiting now
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) — Recruiting now
• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors — Recruiting now
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection — Recruiting now
• Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy — Recruiting now
• FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Running, not enrolling
• Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
• A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer — Stopped early
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Completed
• 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors — Stopped early
• A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers — Completed
• Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — TEMPORARILY_NOT_AVAILABLE